These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8154018

  • 1. Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador.
    Krause G, Kroeger A.
    Trans R Soc Trop Med Hyg; 1994; 88(1):92-4. PubMed ID: 8154018
    [Abstract] [Full Text] [Related]

  • 2. [Successful topical treatment of chronic cutaneous leishmaniasis with paromomycin sulfate (15%) and methylbenzethonium chloride (12%)].
    Schallreuter KU, Lemke KR.
    Hautarzt; 1994 Nov; 45(11):783-6. PubMed ID: 7822205
    [Abstract] [Full Text] [Related]

  • 3. Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala.
    Arana BA, Mendoza CE, Rizzo NR, Kroeger A.
    Am J Trop Med Hyg; 2001 Nov; 65(5):466-70. PubMed ID: 11716099
    [Abstract] [Full Text] [Related]

  • 4. Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study.
    Soto J, Fuya P, Herrera R, Berman J.
    Clin Infect Dis; 1998 Jan; 26(1):56-8. PubMed ID: 9455509
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.
    Armijos RX, Weigel MM, Calvopiña M, Mancheno M, Rodriguez R.
    Acta Trop; 2004 Jul; 91(2):153-60. PubMed ID: 15234664
    [Abstract] [Full Text] [Related]

  • 6. Topical treatment of cutaneous leishmaniasis.
    El-On J, Livshin R, Even-Paz Z, Hamburger D, Weinrauch L.
    J Invest Dermatol; 1986 Aug; 87(2):284-8. PubMed ID: 3734476
    [Abstract] [Full Text] [Related]

  • 7. Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimonate.
    Soto J, Hernandez N, Mejia H, Grogl M, Berman J.
    Clin Infect Dis; 1995 Jan; 20(1):47-51. PubMed ID: 7727669
    [Abstract] [Full Text] [Related]

  • 8. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
    Grogl M, Schuster BG, Ellis WY, Berman JD.
    J Parasitol; 1999 Apr; 85(2):354-9. PubMed ID: 10219319
    [Abstract] [Full Text] [Related]

  • 9. Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study.
    el-On J, Halevy S, Grunwald MH, Weinrauch L.
    J Am Acad Dermatol; 1992 Aug; 27(2 Pt 1):227-31. PubMed ID: 1430361
    [Abstract] [Full Text] [Related]

  • 10. Topical treatment of recurrent cutaneous leishmaniasis with ointment containing paromomycin and methylbenzethonium chloride.
    el-On J, Weinrauch L, Livshin R, Even-Paz Z, Jacobs GP.
    Br Med J (Clin Res Ed); 1985 Sep 14; 291(6497):704-5. PubMed ID: 3929905
    [No Abstract] [Full Text] [Related]

  • 11. Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment of American cutaneous leishmaniasis: controlled study.
    Krause G, Kroeger A.
    Clin Infect Dis; 1999 Aug 14; 29(2):466-7. PubMed ID: 10476776
    [No Abstract] [Full Text] [Related]

  • 12. Protection of guinea pigs against cutaneous leishmaniasis by combined infection and chemotherapy.
    El-On J, Witztum A, Schnur LF.
    Infect Immun; 1986 Feb 14; 51(2):704-6. PubMed ID: 3943909
    [Abstract] [Full Text] [Related]

  • 13. Studies on the topical treatment of experimental cutaneous leishmaniasis: the therapeutic effect of methyl benzethonium chloride and the aminoglycosides, gentamicin and paromomycin.
    Carter KC, Alexander J, Baillie AJ.
    Ann Trop Med Parasitol; 1989 Jun 14; 83(3):233-9. PubMed ID: 2604461
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran.
    Iraji F, Sadeghinia A.
    Ann Trop Med Parasitol; 2005 Jan 14; 99(1):3-9. PubMed ID: 15701249
    [Abstract] [Full Text] [Related]

  • 15. Topical treatment of New World cutaneous leishmaniasis in Belize: a clinical study.
    Weinrauch L, Cawich F, Craig P, Sosa JX, el-On J.
    J Am Acad Dermatol; 1993 Sep 14; 29(3):443-6. PubMed ID: 8349861
    [Abstract] [Full Text] [Related]

  • 16. Leishmania major: histopathological responses before and after topical treatment in experimental animals.
    El-On J, Lang E, Kuperman O, Avinoach I.
    Exp Parasitol; 1989 Feb 14; 68(2):144-54. PubMed ID: 2924878
    [Abstract] [Full Text] [Related]

  • 17. Leishmania major: resistance of promastigotes to paromomycin, and susceptibility of amastigotes to paromomycin-methylbenzethonium chloride ointment.
    el-On J, Sulitzeanu A, Schnur LF.
    Ann Trop Med Parasitol; 1991 Jun 14; 85(3):323-8. PubMed ID: 1746981
    [Abstract] [Full Text] [Related]

  • 18. Non-ulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin.
    Neva FA, Ponce C, Ponce E, Kreutzer R, Modabber F, Olliaro P.
    Trans R Soc Trop Med Hyg; 1997 Jun 14; 91(4):473-5. PubMed ID: 9373659
    [Abstract] [Full Text] [Related]

  • 19. Leishmania major: bacterial contamination of cutaneous lesions in experimental animals.
    el-On J, Sneier R, Elias E.
    Isr J Med Sci; 1992 Dec 14; 28(12):847-51. PubMed ID: 1286954
    [Abstract] [Full Text] [Related]

  • 20. Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod.
    El-On J, Bazarsky E, Sneir R.
    Exp Parasitol; 2007 Jun 14; 116(2):156-62. PubMed ID: 17306255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.